114 related articles for article (PubMed ID: 38754132)
1. A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of
Long MB; Gilmour A; Kehl M; Tabor DE; Keller AE; Warrener P; Gopalakrishnan V; Rosengren S; Crichton ML; McIntosh E; Giam YH; Keir HR; Brailsford W; Hughes R; Belvisi MG; Sellman BR; DiGiandomenico A; Chalmers JD
Am J Respir Crit Care Med; 2024 Jul; 210(1):35-46. PubMed ID: 38754132
[No Abstract] [Full Text] [Related]
2. Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide.
Thaden JT; Keller AE; Shire NJ; Camara MM; Otterson L; Huband M; Guenther CM; Zhao W; Warrener P; Stover CK; Fowler VG; DiGiandomenico A
J Infect Dis; 2016 Feb; 213(4):640-8. PubMed ID: 26333940
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Antibody MEDI3902, Are Conserved Among Diverse Global Clinical Isolates.
Tabor DE; Oganesyan V; Keller AE; Yu L; McLaughlin RE; Song E; Warrener P; Rosenthal K; Esser M; Qi Y; Ruzin A; Stover CK; DiGiandomenico A
J Infect Dis; 2018 Nov; 218(12):1983-1994. PubMed ID: 30016475
[TBL] [Abstract][Full Text] [Related]
4. Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature.
Thanabalasuriar A; Surewaard BG; Willson ME; Neupane AS; Stover CK; Warrener P; Wilson G; Keller AE; Sellman BR; DiGiandomenico A; Kubes P
J Clin Invest; 2017 Jun; 127(6):2249-2261. PubMed ID: 28463232
[TBL] [Abstract][Full Text] [Related]
5. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.
Ranjbar M; Behrouz B; Norouzi F; Mousavi Gargari SL
Mol Immunol; 2019 Dec; 116():98-105. PubMed ID: 31634816
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults.
Yasumoto H; Katoh H; Kinoshita M; Shimizu M; Hamaoka S; Akiyama K; Naito Y; Sawa T
Microbiol Immunol; 2016 Feb; 60(2):114-20. PubMed ID: 26696420
[TBL] [Abstract][Full Text] [Related]
7. A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.
Warrener P; Varkey R; Bonnell JC; DiGiandomenico A; Camara M; Cook K; Peng L; Zha J; Chowdury P; Sellman B; Stover CK
Antimicrob Agents Chemother; 2014 Aug; 58(8):4384-91. PubMed ID: 24841258
[TBL] [Abstract][Full Text] [Related]
8. Association of Biofilm Formation, Psl Exopolysaccharide Expression, and Clinical Outcomes in Pseudomonas aeruginosa Keratitis: Analysis of Isolates in the Steroids for Corneal Ulcers Trial.
Zegans ME; DiGiandomenico A; Ray K; Naimie A; Keller AE; Stover CK; Lalitha P; Srinivasan M; Acharya NR; Lietman TM
JAMA Ophthalmol; 2016 Apr; 134(4):383-9. PubMed ID: 26846404
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
Moriyama K; Wiener-Kronish JP; Sawa T
Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
[TBL] [Abstract][Full Text] [Related]
10. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa.
DiGiandomenico A; Keller AE; Gao C; Rainey GJ; Warrener P; Camara MM; Bonnell J; Fleming R; Bezabeh B; Dimasi N; Sellman BR; Hilliard J; Guenther CM; Datta V; Zhao W; Gao C; Yu XQ; Suzich JA; Stover CK
Sci Transl Med; 2014 Nov; 6(262):262ra155. PubMed ID: 25391481
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 study of MEDI3902, an investigational anti-Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults.
Ali SO; Yu XQ; Robbie GJ; Wu Y; Shoemaker K; Yu L; DiGiandomenico A; Keller AE; Anude C; Hernandez-Illas M; Bellamy T; Falloon J; Dubovsky F; Jafri HS
Clin Microbiol Infect; 2019 May; 25(5):629.e1-629.e6. PubMed ID: 30107283
[TBL] [Abstract][Full Text] [Related]
12. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
Sawa T; Ito E; Nguyen VH; Haight M
Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.
Imamura Y; Yanagihara K; Fukuda Y; Kaneko Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Sawa T; Wiener-Kronish JP; Kohno S
Eur Respir J; 2007 May; 29(5):965-8. PubMed ID: 17301098
[TBL] [Abstract][Full Text] [Related]
14. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
[TBL] [Abstract][Full Text] [Related]
15. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
[TBL] [Abstract][Full Text] [Related]
16. Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against
Wan C; Zhang J; Zhao L; Cheng X; Gao C; Wang Y; Xu W; Zou Q; Gu J
Front Immunol; 2019; 10():781. PubMed ID: 31068928
[No Abstract] [Full Text] [Related]
17. PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury.
Wang Q; Li H; Zhou J; Zhong M; Zhu D; Feng N; Liu F; Bai C; Song Y
Respir Physiol Neurobiol; 2014 Mar; 193():21-8. PubMed ID: 24418353
[TBL] [Abstract][Full Text] [Related]
18. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
Naito Y; Hamaoka S; Kinoshita M; Kainuma A; Shimizu M; Katoh H; Moriyama K; Ishii KJ; Sawa T
Microbiol Immunol; 2018 Dec; 62(12):774-785. PubMed ID: 30378708
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
[TBL] [Abstract][Full Text] [Related]
20. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
